ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 291 filers reported holding ALKERMES PLC in Q2 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $878,372 | -3.7% | 36,447 | +8.2% | 0.02% | -7.4% |
| Q1 2024 | $911,934 | -12.6% | 33,688 | -10.4% | 0.03% | -22.9% |
| Q4 2023 | $1,043,051 | -8.8% | 37,601 | -7.9% | 0.04% | -18.6% |
| Q3 2023 | $1,144,040 | +16.3% | 40,844 | +29.9% | 0.04% | +19.4% |
| Q2 2023 | $983,821 | +23.2% | 31,432 | +11.0% | 0.04% | +16.1% |
| Q1 2023 | $798,594 | +89933.1% | 28,329 | -16.5% | 0.03% | -16.2% |
| Q4 2022 | $887 | -99.9% | 33,930 | -4.4% | 0.04% | +2.8% |
| Q3 2022 | $793,000 | -2.0% | 35,503 | +30.7% | 0.04% | +5.9% |
| Q2 2022 | $809,000 | +20.6% | 27,155 | +6.5% | 0.03% | +47.8% |
| Q1 2022 | $671,000 | +20.3% | 25,495 | +6.2% | 0.02% | +27.8% |
| Q4 2021 | $558,000 | -28.3% | 23,999 | -4.8% | 0.02% | -35.7% |
| Q3 2021 | $778,000 | +34.4% | 25,219 | +6.8% | 0.03% | +33.3% |
| Q2 2021 | $579,000 | +166.8% | 23,610 | +117.3% | 0.02% | +133.3% |
| Q4 2020 | $217,000 | – | 10,865 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,030,639 | $51,872,000 | 38.88% |
| Tamarack Capital Management, LLC | 525,000 | $25,573,000 | 5.22% |
| Gerry Farber, LLC | 83,000 | $4,177,000 | 4.33% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 140,375 | $7,065,000 | 2.71% |
| Rhenman & Partners Asset Management AB | 168,000 | $8,455,000 | 2.51% |
| First Light Asset Management, LLC | 63,684 | $3,205,000 | 2.16% |
| Iguana Healthcare Management, LLC | 85,000 | $4,278,000 | 2.00% |
| Granahan Investment Management | 1,057,300 | $53,214,000 | 1.55% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,602,431 | $181,310,000 | 1.33% |
| Cormorant Asset Management, LP | 100,000 | $5,033,000 | 1.33% |